Effect of gender difference on platelet reactivity.

Area of Science:

• Cardiology
• Pharmacology
• Hematology

Background:

• Previous research indicates potential gender disparities in antiplatelet medication efficacy.
• The underlying physiological mechanisms and clinical significance of this gender gap remain unclear.

Purpose of the Study:

• To investigate gender differences in on-treatment platelet reactivity.
• To determine if these differences impact clinical outcomes in patients undergoing coronary stent implantation.

Main Methods:

• Assessed on-treatment platelet reactivity in 717 men and 234 women using light transmittance aggregometry (LTA) and VerifyNow assays.
• Evaluated the incidence of major adverse cardiovascular events, including death, myocardial infarction, stent thrombosis, and stroke.

Main Results:

• Women had higher baseline platelet counts and greater on-clopidogrel platelet reactivity compared to men.
• On-aspirin platelet reactivity showed mixed results between the two assays used.
• Despite higher reactivity, the incidence of clinical endpoints was similar between genders.

Conclusions:

• While women exhibit higher platelet reactivity on dual antiplatelet therapy, the difference is small.
• The study suggests that increased platelet reactivity in women does not translate to a higher risk of adverse cardiovascular events.
• Gender-related differences in platelet reactivity are unlikely to be the sole cause of worse prognosis in women.